MOLOXAN

This brand name is authorized in Nigeria.

Active ingredients

The drug MOLOXAN contains one active pharmaceutical ingredient (API):

1	Moxifloxacin UNII C53598599T - MOXIFLOXACIN HYDROCHLORIDE
	Moxifloxacin, a fourth-generation fluoroquinolone, has in vitro activity against a wide range of Gram-positive and Gram-negative pathogens. The bactericidal action of moxifloxacin results from the inhibition of both type II topoisomerases (DNA gyrase and topoisomerase IV) required for bacterial DNA replication, transcription and repair.
	Read more about Moxifloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-8885	Eye drops	MOLOXAN EYE DROPS SOL_DROPS 0.5% 1x10	MOLOXAN EYE DROPS MOXIFLOXACIN Moxifloxacin Ophthalmic Solution USP 0.5%w/v Excipients: Borax, Boric Acid, Sodium Chloride A4-8885 Drugs Imported Products 1x10 Prescription Only Medicine (POM) 30/01/2020 SKT HEALTHCARE PHARMACEUTICALS LTD, OGUNLOWO ST OFF AWOLOWO WAY IKEJA IKEJA LAGOS 14534862 info@sktpharma.com NITIN LIFESCIENCES LIMITED, RAMPUR GHAT ROAD, PAONTA SAHIB,DISTRICT-SIRMOUR (H.P.)- 173 025, INDIA, India	31/08/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01AE07		S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AE Fluoroquinolones
Discover more medicines within S01AE07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-8885